series-b
Stage
1
Investors
About
Mersana Therapeutics is a clinical-stage biopharmaceutical company developing antibody-drug conjugates (ADCs) and other targeted drug-delivery therapies for cancer using proprietary platform technologies to optimize payload delivery and tumor specificity.
Explore Mersana Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.